Format

Send to

Choose Destination
Crit Rev Oncog. 2015;20(3-4):227-43.

Pediatric Rhabdomyosarcoma.

Author information

1
Genetics Branch, Oncogenomics Section, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland; Pediatric Oncology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.

Abstract

Rhabdomyosarcoma is the most common soft-tissue sarcoma of childhood, and despite clinical advances, subsets of these patients continue to suffer high levels of morbidity and mortality associated with their disease. Recent genetic and molecular characterization of these tumors using sophisticated genomics techniques, including next-generation sequencing experiments, has revealed multiple areas that can be exploited for new molecularly targeted therapies for this disease.

PMID:
26349418
PMCID:
PMC5486973
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BegellHouse Publisher, Inc. Icon for PubMed Central
Loading ...
Support Center